Weyburn, Saskatchewan
How to Change Your MindWeyburn, Saskatchewan, was a remote prairie community that became one of the most consequential sites in the early history of psychedelic research. Its Saskatchewan Mental Hospital drew Humphry Osmond and Abram Hoffer into sustained experiments with LSD, including a treatment for alcoholism that brought the subjective experience of the drug into the center of psychiatric debate. The results made Weyburn a hub of international interest, while later attempts to reproduce them exposed how much the treatment depended on the circumstances surrounding a session.
A research center on the prairie
In the mid-1940s, Saskatchewan’s leftist government began using generous public funding and unusual latitude for researchers to make the province a center of advanced medical work. Its reforms included the country’s first publicly funded health-care system, which became a model for Canada’s national system in 1966. The government’s invitation to Osmond followed a less hospitable period at St. George’s Hospital, where his mescaline research had received little support. After answering an advertisement in the Lancet, he was invited to move his family and research project to Weyburn, about forty-five miles north of the North Dakota border.
The Saskatchewan Mental Hospital soon became an important base for research into compounds then called psychotomimetics. Osmond and Hoffer began work with LSD-25 supplied by Sandoz, initially within a framework that treated the drug’s effects as a temporary imitation of psychosis. In 1953, Maclean’s brought that interpretation to a broad Canadian readership with My 12 Hours as a Madman, an account by Sidney Katz, the first civilian participant in one of the Weyburn experiments. Having expected madness, Katz described frightening transformations of familiar faces and surroundings, alongside visions of extraordinary beauty. His report showed how readily an experimental account could reinforce the psychotomimetic interpretation, even when the experience it described was not simply one of horror.
The alcoholism treatment experiments
At Weyburn, Osmond and Hoffer developed a striking application of that model. Their hypothesis was that a single high-dose LSD session might produce a delirium resembling delirium tremens, startling a person with alcoholism into sobriety. Over the next decade they tested the approach on more than seven hundred people. They reported that roughly half became sober and remained so for at least several months, and judged the treatment more effective than other therapies available to them.
The experiment also carried a larger implication. Hoffer later emphasized that the researchers considered the experience, not merely the chemical, a key element of treatment. That emphasis cut across behaviorist approaches that treated subjective experience as irrelevant to scientific explanation. At Weyburn, reports from participants therefore mattered not just as descriptions of side effects, but as evidence about what might make therapy work.
Those reports gradually unsettled the original theory. The sessions did sometimes include hallucinations, paranoia, or anxiety, but many participants described positive experiences, including a sense of unity with the world, heightened perception, and the ability to see themselves objectively. For many of the alcoholics treated at the hospital, the experience seemed closer to transcendence or spiritual insight than to temporary psychosis. Osmond and Hoffer began to question whether the prevailing model—and the name psychotomimetic—mistook visionary or mystical experiences for insanity.
Setting, replication, and dispute
The researchers also learned that the surroundings and interpersonal conditions of a session could affect what participants experienced. They came to value an engaged, empathetic therapist, ideally one with personal experience of LSD, and suspected that a clinical atmosphere of impersonal observation could contribute to difficult reactions. Though the phrase Set and setting became associated with psychedelic research later, Osmond and Hoffer were already recognizing the importance of those factors in Weyburn’s treatment work.
By the end of the 1950s, LSD was widely regarded in North America as a promising treatment for alcohol addiction. Saskatchewan’s government helped make LSD therapy a standard treatment option for alcoholics in the province. But Canadian clinicians at the Addiction Research Foundation in Toronto doubted results they considered too good to be true and set out to replicate the trials under tighter controls in the early 1960s. Their volunteers received LSD in neutral rooms, were instructed to interact with clinicians only through extensive questionnaires, and were sometimes restrained or blindfolded. The outcomes did not match those reported at Weyburn, and several volunteers had terrifying experiences.
The opposing conclusions each captured part of the problem: under these more restrictive conditions, the treatment appeared less effective; at the same time, the replication suggested that attention to Set and setting was integral to the original approach. The contrast made Weyburn’s results difficult to separate from the therapeutic environment in which they had been obtained. It also left a lasting methodological question: whether controlling the context could isolate the drug’s effect, or whether doing so removed part of the treatment itself.
A hub in a wider network
Weyburn’s influence extended beyond the hospital. By the late 1950s, Al Hubbard was visiting to assist Osmond and Hoffer with their work with alcoholics, bringing clinical advice and supplies of LSD as he moved among research groups across North America. His journeys linked Weyburn with other researchers and treatment sites, helping circulate both materials and practical knowledge. The hospital thus belonged not only to a provincial research initiative but also to a developing network of psychedelic practice.
The location remained a landmark in the history of the field even as later researchers challenged the strength of its clinical claims. The first wave of psychedelic research and the underground therapists who carried practices forward both contributed to the later revival of research, while exchanges between university teams and underground guides continued. Weyburn’s particular contribution was an early demonstration that the therapeutic meaning of LSD could not be understood solely through a model of induced madness: reported experience, therapeutic relationship, and setting all formed part of the evidence and the treatment.